miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushmiRNAs in breast cancer tumorigenesis (Review)Regulation of mesenchymal phenotype by MicroRNAs in cancerMolecular mechanisms of epithelial-mesenchymal transitionIdentification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTmiR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsThe role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.A statistically inferred microRNA network identifies breast cancer target miR-940 as an actin cytoskeleton regulatorMIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model.MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating proteinThe expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis.Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling.MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasisHuman Blastocyst Secreted microRNA Regulate Endometrial Epithelial Cell Adhesion.MicroRNA expression profiles differentiate chronic pain condition subtypes.Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.TIP60-miR-22 axis as a prognostic marker of breast cancer progression.Role of microRNAs in breast cancer.MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.Novel strategies targeting cancer stem cells through phytochemicals and their analogsSNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.miR-661 downregulates both Mdm2 and Mdm4 to activate p53.Dissecting the chromatin interactome of microRNA genes.ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.MicroRNA control of epithelial-mesenchymal transition and metastasis.MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs.MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
P2860
Q26741215-CC0719CD-B68E-4BD8-957E-135BD50FD649Q26824561-071D6098-F485-4536-AD05-B4E4B080269AQ27009506-1B1539EC-C7B8-475E-8D96-BEE374D95C4EQ27013743-BB6D487D-3B09-475B-8BC5-2451C33C37D1Q28744173-23B715E5-E1AF-4F9B-9710-3618A712CF68Q30540092-94BDF4F1-7383-4A9D-A6EA-08D751876EA0Q30883662-6D870581-AC65-49F3-BC86-6C3D8D20B6ECQ33556392-574BF7E8-C9D4-429D-A12D-4A929D74BF5BQ33837392-1453ECE3-A528-4F4D-837C-1A9084E7CA45Q33913045-C0F523C9-950D-48EF-9F5B-320398929DB4Q34197212-0C00A8EC-C198-45C9-8D9F-B39994E3C188Q34208986-F01BB8FB-3502-425E-B2C3-B85468719CA1Q35053054-8000D942-F1AD-404C-BFEB-AEF308B96E4CQ35080037-C68584E4-DC68-4F3E-A0BC-B04291EF9AADQ35176272-E923B071-E0A2-45D3-986F-CD1D3C3115CCQ35688456-E5CA7602-FE5B-41A6-A6C2-ECFD3CDF1777Q35795725-63EE49C0-A498-4586-94BE-E821AC3D2B75Q36253101-D50151D1-74E2-45E4-80D6-28166A6A2230Q36307621-D1B5310D-09FF-4DD1-913A-D90BCBB5DC69Q36527551-641446EC-5956-407E-9B2E-92DFFA7A3DC3Q36562356-ED33E5EA-C259-4915-A6CB-82543944AA3DQ36677690-835D3FD6-116D-466E-88C6-74B63AB21A3EQ37086059-ACF011C8-9018-4FE7-866C-3F41392A7160Q37198168-D4C4659A-A5C0-4F59-A856-893F9F910906Q37352692-D23B6322-D9F9-4788-81EC-88D611C36C50Q37475492-47AA26F6-6EEE-401F-9167-87E3BE67276FQ37631820-FB019D5C-B545-4866-B559-07AAFF3EE78DQ37641594-7E869E07-D304-4CDF-8A96-DEE835C84E84Q37681322-D838462F-061B-4098-A207-B76733331917Q37694781-CFF8CB4D-EC2A-4C64-94A5-74F3C450790FQ37828424-C021B9B7-0487-4D12-A661-E7931B922D01Q37933095-535189A5-C7E4-4FCA-AFA6-ED70D61887B8Q37941371-FA5D3418-A580-4E76-985B-0809B172E509Q37970478-7319C072-0683-417A-A641-43FAD5B71687Q38017596-9E0196C7-D0A1-417C-BCA3-20BD4466C5C2Q38043263-F4AC2ECF-8D9C-4DAF-A614-F297EF9E2A48Q38083976-1F166A82-5E53-4DA0-AAD5-1BFD241C3DFFQ38185615-21ED9BC9-183A-4246-B7C6-388F4B36F7B3Q38309242-B68FACE4-933C-43D3-9120-24E944F80048Q38336073-2BA81808-B2AD-468D-B825-0AC40DCC798D
P2860
miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@ast
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@en
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@nl
type
label
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@ast
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@en
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@nl
prefLabel
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@ast
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@en
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@nl
P2093
P2860
P356
P1433
P1476
miR-661 expression in SNAI1-in ...... ctin-1 and StarD10 messengers.
@en
P2093
A Le Béchec
C-H Lecellier
E Friederich
P2860
P2888
P304
P356
10.1038/ONC.2010.181
P407
P577
2010-06-14T00:00:00Z
P5875
P6179
1035595033